Where is the live CopyMark page for USPTO serial 74417278?

The live record is at https://getcopymark.com/trademark/74417278. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns EPAXAL BERNA?

According to the public USPTO record for serial number 74417278, the listed owner(s) include: Swiss Serum and Vaccine Institute and Institute for the Research of Infectious Diseases, Swiss Serum and Vaccine Institute and Institute for the Research of Infectious Diseases.

What is USPTO serial number 74417278?

Serial number 74417278 is the USPTO application identifier for the mark EPAXAL BERNA. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover EPAXAL BERNA?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

USPTO serial 74417278

EPAXAL BERNA

Q: What is the current status of EPAXAL BERNA?

EPAXAL BERNA (74417278) currently shows USPTO status code 605 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Reviewed by CopyMark Law Group

Status 605

Filing date: Jul 23, 1993
Status date: Dec 15, 1994
Registration date: —
Examiner: VLCEK, TOMAS V
Law office: FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EPAXAL BERNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE REZAC & SCHWAB708 THIRD AVENEW YORK, NY 10017-4141UNITED STATES

Goods and services

Class	Description	Status	First use
005	vaccines to prevent hepatitis-A	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Dec 15, 1994	ABN5	ABANDONMENT - AFTER PUBLICATION	—
Dec 15, 1994	OP.T	OPPOSITION TERMINATED NO. 999999	—
Dec 15, 1994	OP.S	OPPOSITION SUSTAINED NO. 999999	—
Dec 15, 1994	OP.S	OPPOSITION SUSTAINED NO. 999999	—
Sep 1, 1994	OP.I	OPPOSITION INSTITUTED NO. 999999	—
Mar 4, 1994	ETOF	EXTENSION OF TIME TO OPPOSE RECEIVED	—
Feb 1, 1994	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 31, 1993	NPUB	NOTICE OF PUBLICATION	—
Dec 1, 1993	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Nov 26, 1993	CNEA	EXAMINER'S AMENDMENT MAILED	—
Nov 23, 1993	1.BD	Sec. 1(B) CLAIM DELETED	—
Nov 15, 1993	DOCK	ASSIGNED TO EXAMINER	—